Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan - ScienceDirect
Miami Dade Provides Leadership, Foundation For Community Colleges | Diverse: Issues In Higher Education